Abstract
Background
Frailty is the most important short- and long-term predictor of disability in the elderly and, thus, might influence the clinical outcome of acute treatment of stroke.
Objective
To evaluate whether frailty predicts short- and long-term all-cause mortality and neurological recovery in elderly patients who underwent reperfusion acute treatment of stroke.
Methods
The study included consecutive patients older than 65 years who underwent reperfusion treatment in a single stroke unit from 2015 to 2016. Predictors of stroke outcomes were assessed including demographics, baseline NIHSS, time to needle, treatment and medical complications. Premorbid frailty was assessed with a comprehensive geriatric assessment including functional, nutritional, cognitive, social and comorbidities status. At three and twelve months, all-cause death and clinical recovery (using modified Rankin scale, mRS) were evaluated.
Results
One-hundred and two patients who underwent acute reperfusion treatment for stroke entered the study (mean age 77.5, 65–94 years). Frailty was diagnosed in 32 out of 102 patients and associated with older age (p = 0.001) but no differences in baseline NIHSS score, vascular risk profile or treatment management strategy. Frailty status was associated with worse improvement at 24 h and higher in-hospital mortality. At follow-up, frail patients showed poorer survival at 3 (25% vs 3%, p = 0.008) and 12 (38% vs 7%, p = 0.001) months. Frailty was the best predictor of neurological recovery at one year follow-up (mRS 3.2 ± 1.9 vs 1.9 ± 1.9).
Discussion
Frailty is an important predictor of efficacy of acute treatment of stroke beyond classical predictors of stroke outcomes. Larger longitudinal studies are, thus, warranted to evaluate the risk–benefit of reperfusion treatment in the growing elderly frail population.
References
Powers WJ, Rabinstein A, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update. Stroke 50(12):e344–e418
Padovani A, Pilotto A (2020) Looking at the burden of neurological disorders in Europe. Lancet Public Health 5(10):523
Appelros P, Nydevik I, Viitanen M (2003) Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke 34(1):122–126
Winovich DT, Longstreth WTJ, Arnold AM, Varadhan R, Hazzouri AZA, Cushman M, Newman AB, Odden MC (2017) Factors associated with ischemic stroke survival and recovery in older adults. Stroke 48(7):1818–1826
Sharrief A, Grotta JC (2019) Stroke in the elderly. Handb Clin Neurol 167:393–418
Yourman LC, Sei JL, Schonberg MA, Widera EW, Smith AK (2012) Prognostic indices for older adults: a systematic review. JAMA 307(2):182–192
Evans NR, Wall J, To B, Wallis SJ, Romero-Ortuno R, Warburton EA (2020) Clinical frailty independently predicts early mortality after ischaemic stroke. Age Ageing 49(4):588–591
Wæhler IS, Saltvedt I, Lydersen S, Fure B, Askim T, Einstad MS, Thingstad P (2021) Association between in-hospital frailty and health-related quality of life after stroke: the Nor-COAST study. BMC Neurol 21(1):100
Kilkenny MF, Phan HT, Lindley RI, Kim J, Lopez D, Dalli LL, Grimley R, Sundararajan V, Thrift AG, Andrew NE, Donnan GA, Cadilhac DA, Stroke123 Investigators and the AuSCR Consortium (2021) Utility of the hospital frailty risk score derived from administrative data and the association with stroke outcomes. Stroke 52(9):2874–2881
Sancarlo D, Pilotto A, Panza F, Copetti M, Longo MG, D’ambrosio P, D’Onofrio G, Ferrucci L, Pilotto A (2012) A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack. J Neurol 259(4):670–678
Pinho J, Kueppers C, Nikoubashman O, Wiesman M, Schulz JB, Reich A, Werner CJ (2021) Frailty is an outcome predictor in patients with acute ischemic stroke receiving endovascular treatment. Age Ageing 50(5):1785–1791
Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J (1994) Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group Stroke 25(11):2220–2226
Pilotto A, Ferrucci L, Franceschi M, D’Ambrosio LP, Scarcelli C, Cascavilla L, Paris F, Placentino G, Seripa D, Dallapiccola B, Leandro G (2008) Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rej Res 11(1):151–161
Kugler C, Altenhöner T, Lochner P, Ferbert A (2003) Does age influence early recovery from ischemic stroke? A study from the Hessian Stroke Data Bank. J Neurol 250(6):676–681
Chen CJ, Ding D, Starke RM, Mehndiratta P, Crowley RW, Liu KC, Southerland AM, Worrall BB (2015) Endovascular vs medical management of acute ischemic stroke. Neurology 85(22):1980–1990
Kanai M, Noguchi M, Kubo H, Nozoe M, Kitano T, Izawa KP, Mase K, Shimada S (2020) Pre-stroke frailty and stroke severity in elderly patients with acute stroke. J Stroke Cerebrovasc Dis 29(12):105346
Ohba H, Ohbayashi N, Fukuda H, Yahara K, Nabika S, Suto Y, Tokuda N, Yoshida K, Nakaoka M, Sakamoto S (2021) Predictors of reperfusion and 90-day functional outcome after mechanical thrombectomy for large vessel occlusion strokes. J Stroke Cerebrovasc Dis 30(5):105687
Fujita K, Tanaka K, Yamagami H, Yoshimoto T, Uchida K, Morimoto T, Imamura H, Sakai N, Ohara N, Matsumoto Y et al (2021) Outcomes of large vessel occlusion stroke in patients aged ≥ 90 years. Stroke 52(5):1561–1569
Bu N, Khlif MS, Lemmens R, Wouters A, Fiebach JB, Chamorro A, Ringelstein EB, Norrving B, Laage R, Grond M et al (2021) Imaging markers of brain frailty and outcome in patients with acute ischemic. Stroke 52:1004–1011
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Competing interest statement regarding the submitted work: None. Competing interest statement outside the submitted work Andrea Pilotto is supported by IMI H2020 initiative (MI2-2018-15-06) paid to the university of Brescia and PRIN funding of the Italian Ministry of Education, Research and University (MIUR) paid to the university of Brescia; he received Lectures honoraria from Bial, Biomarin, Abbvie, CHiesi and Zambon pharmaceuticals-payment made to A.P. as an individual; he received research support from Bial, Biomarin, Abbvie, CHiesi and Zambon pharmaceuticals-payment made to the Institution University of Brescia, Klaus Fassbender, Fatma Merzou, Andrea Morotti, Niklas Kämpfer and Antonio Siniscalchi have no conflict of interests. Alessandro Padovani received grant support from Ministry of Health (MINSAL) and Ministry of Education, Research and University (MIUR), from CARIPLO Foundation; personal compensation as a consultant/scientific advisory board member for Biogen 2019–2020–2021 Roche 2019–2020 Nutricia 2020–2021 General Healthcare (GE) 2019; he received honoraria for lectures at meeting ADPD2020 from Roche, Lecture at meeting of the Italian society of Neurology 2020 from Biogen and from Roche, Lecture at meeting AIP 2020 and 2021 from Biogen and from Nutricia, Educational Consulting 2019–2020–2021 from Biogen. Piergiorgio Lochner has no conflict of interest.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Pilotto, A., Brass, C., Fassbender, K. et al. Premorbid frailty predicts short- and long-term outcomes of reperfusion treatment in acute stroke. J Neurol 269, 3338–3342 (2022). https://doi.org/10.1007/s00415-022-10966-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-022-10966-7